1. Home
  2. HRMY vs HTZ Comparison

HRMY vs HTZ Comparison

Compare HRMY & HTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$31.05

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$6.13

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
HTZ
Founded
2017
1918
Country
United States
United States
Employees
N/A
26000
Industry
Biotechnology: Pharmaceutical Preparations
Rental/Leasing Companies
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
HTZ
Price
$31.05
$6.13
Analyst Decision
Buy
Hold
Analyst Count
9
3
Target Price
$44.11
$5.67
AVG Volume (30 Days)
793.3K
15.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.97
N/A
EPS
2.71
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.75
$4.94
Revenue Next Year
$12.88
$3.62
P/E Ratio
$12.04
N/A
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$3.78
52 Week High
$40.87
$8.44

Technical Indicators

Market Signals
Indicator
HRMY
HTZ
Relative Strength Index (RSI) 51.87 51.91
Support Level $25.92 $4.98
Resistance Level $30.96 $7.24
Average True Range (ATR) 1.47 0.63
MACD 0.07 -0.08
Stochastic Oscillator 35.36 26.51

Price Performance

Historical Comparison
HRMY
HTZ

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

Share on Social Networks: